Celator Pharma Cmn (CPXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2012 | 03-2012 | 12-2011 | |
| Operating Expenses | 2,055 | 1,664 | 0 |
| Operating Income | -2,055 | -1,664 | 0 |
| Interest Expense | 60 | 367 | 0 |
| Other Income | -7 | 1 | 0 |
| Pre-tax Income | -2,122 | -2,030 | 0 |
| Net Income Continuous | -2,122 | -2,030 | 0 |
| Net Income | $-2,122 | $-2,030 | $0 |
| EPS Basic Total Ops | -0.19 | -0.18 | N/A |
| EPS Basic Continuous Ops | -0.19 | -0.18 | N/A |
| EPS Diluted Total Ops | -0.19 | -0.18 | N/A |
| EPS Diluted Continuous Ops | -0.19 | -0.18 | N/A |
| EBITDA(a) | $-1,969 | $-1,578 | $0 |